Home
Investor Resources
TNGN(Common Stock)
ExchangeOTC BB (US Dollar)
Price$0.54
Change (%)0.00 (0.00%)
Volume810
Data as of 06/19/13 10:02 a.m. ET
Minimum 20 minute delay
Refresh quote
What's New
June 12, 2013
Tengion to Participate in Panel Discussion at ISSCR 11th Annual Meeting
WINSTON-SALEM, N.C., June 12, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that Dr. Tim Bertram, the Company's President of Research and Development and Chief Scientific Officer, will participate in a panel at the International Society for Stem Cell Research (ISSCR) 11th Annual Meeting being held June 12th-15th, 2013 in Boston, Massachusetts. Dr. Bertram will take part in a panel discussion titled "Disease-focused Research: From Bench t... 
May 15, 2013
Tengion Provides Business Update and Reports First Quarter 2013 Financial Results
-- Phase 1 trial of Neo-Kidney Augment™ on track for initiation in Sweden in second quarter of 2013 and in U.S. in fourth quarter of 2013 -- -- Actively recruiting for final three patients in Neo-Urinary Conduit™ trial -- WINSTON-SALEM, N.C., May 15, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business update and reported its financial results for the first quarter ended March 31, 2013. "We are very pleased to have achieved a sig...